23andMe, Inc. announced the appointment of Dean Schorno, CPA, as chief financial officer and head of operations for the company. In his new role, Schorno will oversee 23andMe's global financial and clinical laboratory operations. Schorno brings a wealth of experience to the job, most recently, serving as chief financial officer of Adaptive Biotechnologies.

Before that he held executive leadership positions at Genomic Health. As CFO at Adaptive Biotechnologies, Schorno lead all financial operations which included a significant financing and acquisition for the company. He was also responsible for laboratory operations and facilities management.